List of companies in Pappas Capital's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
A medical device company developing surgical products for spine procedures | ||||||
A biopharmaceutical company developing therapeutic products for the treatment of diseases. | ||||||
Tesaro is a biopharmaceutical company focused on identifying cancer therapies, acquired by GSK in 2019. | ||||||
Liquidia Technologies is a Durham, North Carolina-based nanotechnology company focused on development and commercialization of human therapeutics. | ||||||
Ultragenyx Pharmaceutical is a Novato, California-based company. | ||||||
American biopharmaceutical company | ||||||
4D Molecular Therapeutics designs, develops and commercializes products for gene therapy. | ||||||
BioAlta is a San Diego, California-based biotechnology company focused on developing protein therapies for cancer treatment. | ||||||
Chimerix is a company developing antiviral medicines for the treatment of diseases. | ||||||
A cardiovascular genomic diagnostics company that provides clinicians information to improve patient care | ||||||
Kezar Life Sciences is a therapies for autoimmune disorders founded in 2015 by John Fowler. | ||||||
A pharmaceutical company that develops therapies targeting solid and hematological cancer tumors | ||||||
OrphoMed is a clinical-stage biotechnology company with a proprietary dimer therapeutics platform. The company is focused on developing treatments for patients with gastrointestinal disorders. | ||||||
Milestone Pharmaceuticals is a small Molecules founded in 2007. | ||||||
Mirum Pharmaceuticals is developing treatments for liver disease. | ||||||
Selventa is a scientific consulting services company founded in 2002 by Mike Masterson. | ||||||
Mirati Therapeutics is a targeted Oncology Company; Small Molecules founded in 2013 by Charles Baum. | ||||||
Amplyx Pharmaceuticals, Inc. is a preclinical stage company focusing on the development of small molecule drugs. | ||||||
Small molecule drugs that target functional 3D RNA structures to treat human diseases. | ||||||
Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals. | ||||||
A company developing therapeutics for diseases | ||||||
Plexium is a small Molecules Targeting E3 Ligase founded in 2018. | ||||||
Reneo Pharmaceuticals is a Genetically-Defined Orphan Therapies. | ||||||
Envisia Therapeutics is a biotechnology company developing ocular therapies founded in 2013. | ||||||
